Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

A diet rich in fruit, vegetables and whole grains is generally recommended for better health and to lower the risk of cancer ...

MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic window ...

Radon already has a well-earned reputation as a lung cancer threat. Now a systematic review published in Frontiers in Public ...

Pancreatic cancer is one of the most difficult cancers to treat, with an overall five-year survival rate of 13%, according to ...

Share on Pinterest A new study highlights an environmental risk factor that could be driving early onset lung cancer rates.

New research challenges the idea that the thymus becomes inactive in adulthood, pointing instead to a subtle but significant ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune ...

The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it ...

Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover ...

The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...